The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: Report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009

  1. Lookup NU author(s)
  2. Professor Katherine Bushby
  3. Emma Heslop
  4. Dr Pauline McCormack
  5. Dr Simon Woods
Author(s)Muntoni F, Contributors include, Bushby K, Heslop E, McCormack P, Woods S
Publication type Article
JournalNeuromuscular Disorders
Year2010
Volume20
Issue5
Pages355-362
ISSN (print)0960-8966
ISSN (electronic)1873-2364
Full text is available for this publication:
PublisherElsevier
URLhttp://dx.doi.org/10.1016/j.nmd.2010.03.005
DOI10.1016/j.nmd.2010.03.005
NotesReport authored by Francesco Muntoni, on behalf of the meeting steering committee, and of the TREAT-NMD Network. Contributors to this document include: Kate Bushby (Institute of Human Genetics, Newcastle University); Emma Heslop (Institute of Human Genetics, Newcastle University); Pauline McCormack (Policy, Ethics and Life Sciences, Newcastle University); and Simon Woods (Policy, Ethics and Life Sciences, Newcastle University).
Actions    Link to this publication